Status:
COMPLETED
Severe Aortic Valve Stenosis and Concomitant Coronary Artery Disease in Patients Undergoing TAVI
Lead Sponsor:
Örebro County Council
Conditions:
Aortic Valve Stenosis
Coronary Artery Disease
Eligibility:
All Genders
Brief Summary
Patients undergoing surgical aortic valve replacement (sAVR) with concomitant coronary artery disease (CAD) are known to have higher mortality rates compared to patients without CAD. This same phenome...
Detailed Description
A narrowing of the aortic valve, aortic stenosis, is a relatively common condition among the elderly. When the narrowing gets too severe, symptoms such as loss of breath, angina and fainting can occur...
Eligibility Criteria
Inclusion
- All patients that underwent a TAVI procedure at Örebro University Hospital between 2009 till 1st december 2019.
Exclusion
- Patients with procedural-related coronary artery injury and patients with solitary stenosis in a diagonal branch were excluded from the study.
Key Trial Info
Start Date :
December 13 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 24 2020
Estimated Enrollment :
346 Patients enrolled
Trial Details
Trial ID
NCT04385459
Start Date
December 13 2018
End Date
December 24 2020
Last Update
September 9 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department for Cardiothoracic and Vascular Surgery, Örebro University Hospital
Örebro, Sweden, 70185